PubHawk
Diabetes Res Clin Pract May 2025 PMID 40187534

Economic burden of podiatric care for diabetic foot ulcers in the Czech Republic: A prospective multicenter study.

Vladimíra Fejfarová, Miroslav Koliba, Pavlína Piťhová, Milan Flekač, Věra Prýmková, Johana Venerová, Jan Stryja, Martina Košková, Hana Kůsová, Jan Mareš, Alexandra Jirkovská, Jarmila Jirkovská, Bedřich Sixta

Download social card

Mentions

3
Peak: 3 in Aug 2025
across 2 sources since Aug 2025

Extended reach

258
potential audience

Total likes

3

Video views

117

Mentions per month

Aug 2025

All 3 dated mentions so far are from Aug 2025.

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The overall tone of the discussions is neutral, with references like 'another video dedicated to research at #IKEM' indicating curiosity or general interest without critical analysis. The lack of in-depth commentary or reactions about the specific costs or implications of the study suggests minimal impact or engagement from the audience.

AgreementNeither agree nor disagree

Most discussions do not explicitly support or oppose the study's findings, indicating a neutral stance.

InterestModerate interest

The mention of research at #IKEM suggests moderate interest, but there's no deep dive into the content of the publication itself.

EngagementNeutral engagement

The posts seem to provide brief mentions or references without detailed analysis, reflecting superficial engagement.

ImpactNeutral impact

The social discussions do not appear to influence opinions significantly or suggest a major impact on practice or policy.

Abstract in brief

  • The study investigates the financial burden of podiatric care for diabetic foot ulcers (DFUs) in Czech Republic, finding that the average cost per patient over six months is about €2,506, mainly driven by therapeutic procedures and hospital stays.
  • Costs are significantly higher for hospitalized patients compared to outpatients, with hospital services and therapies being the largest expense factors.
  • The research highlights that newly developed DFUs or peripheral artery disease (PAD) do not significantly increase overall costs, suggesting other factors influence the financial burden.]
Read the full abstract

Top posts

Most liked on X and Bluesky
IKEM Research
@IkemResearch · X

We bring you another video dedicated to research at #IKEM.

Aug 28, 2025 · 1 like · 142 followers View post →

All mentions

IKEM Research
@IkemResearch · X

We bring you another video dedicated to research at #IKEM.

Aug 28, 2025 · 1 like · 142 followers View post →